Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
When To Switch From Target Date Fund To Age Based Approach: Go. This intro covers when a switch makes sense and what signals to watch for in your plan.
25,368 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
In a world of market swings, a simple, broad-based approach can anchor your portfolio. The Vanguard Total Stock Marke...
Stock market volatility history teaches a timeless lesson: stay disciplined and automate a simple investing move. Thi...
Dow's Jim Fitterling cautions that the Iran war is disrupting petrochemical supply, potentially fueling inflation thr...
Upscale AI closed a $190 million Series A-1, boosting total funding to $500 million and signaling a bold bid to becom...
Buying a home is a big financial move. Here are nine smart, practical tips from real estate experts to help you save ...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
Saving money doesn't have to be painful. This guide shows you how to trim $500+ from your monthly bills with smart pl...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
A high-profile creator faced a dramatic revenue tumble after backlash, underscoring how follower counts don’t guarant...
Investing often tempts us to cash in quick wins for the next big gain. This guide shows why you should think twice be...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...